calendar
5,172 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
5,172 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion
Sponsor: University of Texas at Austin. Phase: NA. Conditions: Any Non-traumatic Musculoskeletal Condition
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Migraine
Sponsor: University of California, San Francisco. Phase: . Conditions: Cervical Carcinoma, Human Papillomavirus-Related Carcinoma
Sponsor: Sultan Ayaz Alkaya. Phase: NA. Conditions: Disease Self Management
Sponsor: University of Baghdad. Phase: NA. Conditions: Newborn Care
Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Refractory Solid Cancer Patients Unexposed to Immunotherapy
Sponsor: University of British Columbia. Phase: NA. Conditions: Asthma, Healthy, Effect of Drug
Sponsor: Pacific University. Phase: NA. Conditions: Healthy
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: COVID, ARDS, Quality of Life
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Hypertension
Sponsor: Ohio State University. Phase: . Conditions: Bone Grafting, Sinus Lifting
Sponsor: Queen Mary University of London. Phase: . Conditions: Tendinopathy, Musculoskeletal Diseases or Conditions, ACL Surgery, Achilles Tendon Surgery
Sponsor: Centre Leon Berard. Phase: NA. Conditions: Multiple Myeloma, Complication
Sponsor: Nested Therapeutics, Inc. Phase: PHASE1. Conditions: Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Melanoma, NSCLC, Glioma, Solid Tumor, Adult, MAPK Pathway Gene Mutation
Sponsor: Pierre Fabre Medicament. Phase: PHASE2. Conditions: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications, EBV+ Sarcomas, Leiomyosarcoma
Sponsor: Italian Sarcoma Group. Phase: NA. Conditions: Chordoma
Sponsor: Yan'an Affiliated Hospital of Kunming Medical University. Phase: . Conditions: Heart Failure (HF)
Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Pregnant Women, Prenatal Yoga, Trauma, Body Image, Delivery
Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Stroke, Atrial Fibrillation
Sponsor: Northwestern University. Phase: PHASE2. Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Bladder Cancer AJCC v8
Sponsor: University Hospital Tuebingen. Phase: NA. Conditions: Parkinson Disease
Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostatic Neoplasms
Sponsor: Boston University. Phase: . Conditions: HIV
Sponsor: Peking Union Medical College Hospital. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna. Phase: . Conditions: Systemic Juvenile Idiopathic Arthritis (sJIA)
Sponsor: Florida State University. Phase: NA. Conditions: Pain, Acute Pain
Sponsor: Fudan University. Phase: . Conditions: Pancreatic Cancer
Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Schizophrenia Disorder
Sponsor: Replimune, Inc.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Stroke, Caregiver
Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: PHASE2. Conditions: Neurofibromatosis 1
Sponsor: University of Michigan. Phase: NA. Conditions: Mild Cognitive Impairment, Dementia; Alzheimer's Type (Etiology)
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumours
Sponsor: Martini Hospital Groningen. Phase: . Conditions: Burns
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Neoplasms, Lymphoma
Sponsor: Shifa International Hospital. Phase: PHASE1. Conditions: Diabetes, Diabetes Complications, Diabetic Neuropathy
Sponsor: Indiana University. Phase: . Conditions: Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure (CHF), Congestive Heart Failure Chronic
Sponsor: October 6 University. Phase: NA. Conditions: Stroke
Sponsor: Singapore General Hospital. Phase: NA. Conditions: Pressure Injuries, Caregiver, Community Dwelling Older Adult
Sponsor: Tanta University. Phase: PHASE3. Conditions: Chronic Anal Fissure
Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Healthy Participants
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE2. Conditions: Obesity, Diet Therapy, Weight Loss, Weight Gain, Nutrition Therapy
Sponsor: Methodist Health System. Phase: . Conditions: COVID-19
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: ICB-refractory Melanoma
Sponsor: OrthoCarolina Research Institute, Inc.. Phase: NA. Conditions: Phantom Limb Pain After Amputation
Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Substance Use Disorders, Chronic Pain, Opioid Use Disorder, Back Pain Lower Back Chronic
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: COVID-19
Sponsor: Geisinger Clinic. Phase: NA. Conditions: Emergency Service, Hospital
Sponsor: IntoCell, Inc. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Metastatic Solid Tumor
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD